Differentiating celiac disease from other diseases: Difference between revisions
No edit summary |
|||
Line 135: | Line 135: | ||
| | | | ||
* [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]] | * [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]] | ||
* [[Tachycardia]] | |||
*[[Tachycardia]] | |||
*[[Hypotension]] | *[[Hypotension]] | ||
| | | | ||
Line 147: | Line 145: | ||
* Elevated [[C-reactive protein|CRP]] | * Elevated [[C-reactive protein|CRP]] | ||
| | | | ||
* | * Blood seen on [[rectal exam]] | ||
* [[ | * [[Fever]] | ||
|Abnormal immune response to self [[antigens]] | |Abnormal immune response to self [[antigens]] | ||
| | | | ||
Line 156: | Line 154: | ||
| + | | + | ||
| - | | - | ||
| | |Any age | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| | |<nowiki>+/-</nowiki> | ||
| | | | ||
* Lump in the neck | * Lump in the neck | ||
Line 166: | Line 164: | ||
* Increased [[Deep tendon reflex|DTR]] | * Increased [[Deep tendon reflex|DTR]] | ||
| | | | ||
* | * Elevated T4 | ||
* Elevated T3 | |||
* Decreased level of TSH | |||
| | | | ||
* | * Stare | ||
* Lid lag | |||
* Sweating | |||
* Hyperpigmentation | |||
| | | | ||
* Graves' disease | |||
* Hashimoto thyrotoxicosis | |||
* Toxic adenoma | |||
| | | | ||
* [[TSH]] with [[T3]] and [[T4]] | * [[TSH]] with [[T3]] and [[T4]] | ||
Line 176: | Line 182: | ||
| + | | + | ||
| - | | - | ||
| | |between 30 and 50 | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | |<nowiki>+/-</nowiki> | ||
| | |<nowiki>+/-</nowiki> | ||
| | | | ||
* [[Tachycardia]] | * [[Tachycardia]] | ||
Line 188: | Line 194: | ||
* [[Abdominal tenderness]] in the right upper abdominal quadrant | * [[Abdominal tenderness]] in the right upper abdominal quadrant | ||
| | | | ||
* | *hypokalemia | ||
*Hypochlorhydria or achlorhydria | |||
*low osmotic gap (<50 mOsm/kg) | |||
| | | | ||
* [[Dehydration]] | * [[Dehydration]] | ||
Line 194: | Line 202: | ||
* [[Nausea]], [[vomiting]] | * [[Nausea]], [[vomiting]] | ||
* [[Flushing]] | * [[Flushing]] | ||
| | |Primary secretory tumor | ||
| | | | ||
* Elevated [[VIP]] levels | * Elevated [[VIP]] levels | ||
Line 202: | Line 210: | ||
| + | | + | ||
| - | | - | ||
| | |between 30 and 50 | ||
| | |<nowiki>-</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | | | ||
* [[Abdominal tenderness]] | * [[Abdominal tenderness]] | ||
* Hard stool in the rectal vault | * Hard stool in the rectal vault | ||
|<nowiki>-</nowiki> | |||
| | | | ||
* [[Bloating|Bloating]] | |||
* | * [[Flatulence]] | ||
* [[ | |Postinfectious | ||
Inflammatory | |||
| | | | ||
* [[Diagnosis|Clinical diagnosis]] | * [[Diagnosis|Clinical diagnosis]] | ||
Line 223: | Line 232: | ||
| - | | - | ||
| + | | + | ||
| | |Adolescents and increase risk with age | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| | |<nowiki>+/-</nowiki> | ||
| | | | ||
* [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]] | * [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]] | ||
Line 234: | Line 243: | ||
* [[Nausea and vomiting]] | * [[Nausea and vomiting]] | ||
| | | | ||
* [[Bloating|Bloating | * [[Hydrogen Breath Test|Lactose breath hydrogen test]] | ||
| | |||
* [[Bloating|Bloating]] | |||
* [[Flatulence]] | * [[Flatulence]] | ||
* Symptoms begin mainly after ingestion of [[lactose]] | * Symptoms begin mainly after ingestion of [[lactose]] | ||
| | | | ||
| | |lactase activity assay | ||
|- | |- | ||
|[[Whipple's disease|Whipple disease]] | |[[Whipple's disease|Whipple disease]] | ||
| - | | +/- | ||
| + | | + | ||
| | |50th | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
* | * arthralgias of the large joints | ||
* [[Hematochezia]] | |||
| | | | ||
* [[Leukocytopenia]] | * [[Leukocytopenia]] | ||
Line 256: | Line 267: | ||
* [[Skin hyperpigmentation]] | * [[Skin hyperpigmentation]] | ||
* [[Arthralgias]] | * [[Arthralgias]] | ||
| | |''Tropheryma whipplei'' | ||
|Upper [[endoscopy]] with [[biopsies]] of the [[small intestine]] for ''[[Tropheryma whipplei|T. whipplei]]'' testing ([[histology]] with [[Periodic acid-Schiff stain|PAS staining]], [[polymerase chain reaction]] [[[PCR]]] testing, and [[immunohistochemistry]]) | |Upper [[endoscopy]] with [[biopsies]] of the [[small intestine]] for ''[[Tropheryma whipplei|T. whipplei]]'' testing ([[histology]] with [[Periodic acid-Schiff stain|PAS staining]], [[polymerase chain reaction]] [[[PCR]]] testing, and [[immunohistochemistry]]) | ||
|- | |- | ||
Line 276: | Line 287: | ||
* triggered by cow's milk protein | * triggered by cow's milk protein | ||
* profuse, repetitive vomiting | * profuse, repetitive vomiting | ||
| | |Autoimmune/allergic response to food antigens | ||
|[[oral]] food challenge (OFC) | |[[oral]] food challenge (OFC) | ||
|- | |- | ||
Line 296: | Line 307: | ||
* one-half of patients have other [[allergic diseases]] | * one-half of patients have other [[allergic diseases]] | ||
* associated with an identifiable [[dietary]] [[antigen]] | * associated with an identifiable [[dietary]] [[antigen]] | ||
| | |Autoimmune/allergic response to food antigens | ||
|[[eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | |[[eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | ||
|- | |- | ||
Line 321: | Line 332: | ||
** [[Arthritis]] | ** [[Arthritis]] | ||
** [[Uveitis]] | ** [[Uveitis]] | ||
| | |mucosal immune responses to luminal factors in a genetically predisposed individual | ||
| | | | ||
* A [[colonoscopy]] with [[mucosal]] [[biopsy]] with mononuclear infiltrates: | * A [[colonoscopy]] with [[mucosal]] [[biopsy]] with mononuclear infiltrates: | ||
Line 341: | Line 352: | ||
| | | | ||
* History of [[polyhydramnios]] | * History of [[polyhydramnios]] | ||
| | | | ||
[[Mutations]] in the ''SLC26A3'' gene | |||
* Encodes for an [[epithelial]] [[anion]] exchanger | |||
| | | | ||
* Excessive [[Fecal|feca]]<nowiki/>l secretion of [[chloride]] | * Excessive [[Fecal|feca]]<nowiki/>l secretion of [[chloride]] | ||
Line 363: | Line 375: | ||
| | | | ||
* May be associated with [[Choanal atresia|choanal]] or [[anal atresia]] | * May be associated with [[Choanal atresia|choanal]] or [[anal atresia]] | ||
| | |mutations in the ''SPINT2'' gene | ||
| | |Clinical | ||
|- | |- | ||
|[[Glucose|Glucose-]][[galactose]] [[malabsorption]] | |[[Glucose|Glucose-]][[galactose]] [[malabsorption]] | ||
Line 374: | Line 386: | ||
| + | | + | ||
|[[Abdominal tenderness]] | |[[Abdominal tenderness]] | ||
| | |S/E: | ||
* Acidic | |||
| | | | ||
* severe life-threatening [[diarrhea]] | * severe life-threatening [[diarrhea]] | ||
Line 380: | Line 393: | ||
* Symptomatic as long as the diet includes [[lactose]] or its [[hydrolysis]] products, [[glucose]] and [[galactose]] | * Symptomatic as long as the diet includes [[lactose]] or its [[hydrolysis]] products, [[glucose]] and [[galactose]] | ||
| | | | ||
* Mutations in solute carrier family 5, member 1 gene (''SLC5A1'', also known as ''SGLT1'') | |||
** Lead to deficiency in the intestinal sodium/glucose transporter | |||
| | | | ||
* positive [[glucose]] breath [[hydrogen]] test + normal intestinal [[biopsy]] | * positive [[glucose]] breath [[hydrogen]] test + normal intestinal [[biopsy]] | ||
Line 400: | Line 415: | ||
Low [[vitamin E]] levels | Low [[vitamin E]] levels | ||
|[[Clumsiness]] | | | ||
vision impairment | * [[Clumsiness]] | ||
* vision impairment | |||
[[Ataxia]] | * [[Ataxia]] | ||
| | | | ||
* [[autosomal recessive]] disorder caused by mutations encoding the [[microsomal]] [[triglyceride]] transfer protein (MTP) | * [[autosomal recessive]] disorder caused by mutations encoding the [[microsomal]] [[triglyceride]] transfer protein (MTP) | ||
Line 417: | Line 432: | ||
| - | | - | ||
| | | | ||
|Disease | * Low Vitamin A-K-E-D | ||
* Anemia | |||
| | |||
* Disease hetergenicity lead to varying presentation from chronic [[diarrhea]] without significant fat [[Malabsorption|malabsorptio]]<nowiki/>n to severe [[watery diarrhea]] and steatorrhea with [[malnutrition]] | |||
| | | | ||
* [[genetic defects]] in ''SLC10A2'' (solute carrier family 10 member 2 gene) | * [[genetic defects]] in ''SLC10A2'' (solute carrier family 10 member 2 gene) | ||
Line 447: | Line 465: | ||
| +/- | | +/- | ||
| + | | + | ||
|Mild to moderate upper [[abdominal tenderness]] | | | ||
|Positive [[secretin]] stimulation test | * Mild to moderate upper [[abdominal tenderness]] | ||
Elevated serum [[chromogranin A]] | | | ||
|[[heartburn]] | * Positive [[secretin]] stimulation test | ||
* Elevated serum [[chromogranin A]] | |||
| | |||
* [[heartburn]] | |||
|[[Gastrin]] producing tumor mainly in [[duodenum]] | |[[Gastrin]] producing tumor mainly in [[duodenum]] | ||
|elevated basal or stimulated serum [[gastrin]] more than 1000 pg/mL | |elevated basal or stimulated serum [[gastrin]] more than 1000 pg/mL |
Revision as of 11:13, 13 September 2017
Celiac disease Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Differentiating celiac disease from other diseases On the Web |
American Roentgen Ray Society Images of Differentiating celiac disease from other diseases |
Differentiating celiac disease from other diseases in the news |
Risk calculators and risk factors for Differentiating celiac disease from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Differentiating Celiac Disease from Other Diseases
Celiac disease must be differentiated from other diseases presenting as chronic diarrhea. The table below summarizes the findings that differentiate causes of chronic diarrhea[1][2][3][4][5][6][7]
Cause | Diarrhea | Age of onset | History | Physical exam | Lab findings | Additional finding | Cause | Gold standard dignosis | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Watery | Fatty | Weight loss | FTT | Abdominal pain | |||||||
Celiac disease | +/- | +/- | Childhood
Adult |
+ | + | + |
|
|
|
| |
Lactose intolerance | + | - | Adult | - | - | + |
|
|
| ||
Cystic fibrosis | - | + | Infancy and childhood | + | + | + |
|
|
|
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein |
|
Laxative overuse | + | - | After childhood | +/- | - | +/- |
|
|
- | Laxative drug abuse |
|
Crohns disease | + | - | Young adults
(20th) |
+ | + |
|
|
|
Abnormal immune response to self antigens |
| |
Hyperthyroidism | + | - | Any age | + | - | +/- |
|
|
|
||
VIPoma | + | - | between 30 and 50 | + | +/- | +/- |
|
|
Primary secretory tumor |
| |
Irritable bowel syndrome | + | - | between 30 and 50 | - | - | + |
|
- | Postinfectious
Inflammatory |
| |
lactose intolerance | - | + | Adolescents and increase risk with age | + | - | +/- |
|
|
lactase activity assay | ||
Whipple disease | +/- | + | 50th | + | - | + |
|
Tropheryma whipplei | Upper endoscopy with biopsies of the small intestine for T. whipplei testing (histology with PAS staining, polymerase chain reaction [[[PCR]]] testing, and immunohistochemistry) | ||
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | + | - | Infancy | +/- | +/- | + | S/E:
|
|
Autoimmune/allergic response to food antigens | oral food challenge (OFC) | |
Eosinophilic gastroenteritis | + | - | 3rd decade | +/- | +/- | + |
|
Autoimmune/allergic response to food antigens | eosinophilic infiltration of the gastrointestinal tract on biopsy | ||
Microscopic colitis | + | - | 6th decde | + | - | + |
|
mucosal immune responses to luminal factors in a genetically predisposed individual |
| ||
Congenital chloride diarrhea | + | - | Neonate | + | + | - | - |
|
Mutations in the SLC26A3 gene
|
||
Congenital sodium diarrhea | + | - | Neonate | + | + | - | - | S/E: |
|
mutations in the SPINT2 gene | Clinical |
Glucose-galactose malabsorption | + | - | Infancy | + | +/- | + | Abdominal tenderness | S/E:
|
|
|
|
Abetalipoproteinemia | - | + | Infancy | + | + | + | Abdominal distention
Impaired visual acuity and visual field defects |
Low triglyceride
Low total cholesterol levels Low vitamin E levels |
|
|
Clinical findings and low triglyceride and cholesterol level |
Primary bile acid malabsorption | + | +/- | Childhood Adolescents | + | + | +/- | - |
|
|
|
|
Cause | Diarrhea | Age of onset | History | Physical exam | Lab findings | Additional finding | Cause | Gold standard dignosis | |||
Watery | Fatty | Weight loss | FTT | Abdominal pain | |||||||
Gastrinoma (Zollinger-Ellison syndrome) | + | - | between the ages of 20 and 50 | + | +/- | + |
|
|
Gastrin producing tumor mainly in duodenum | elevated basal or stimulated serum gastrin more than 1000 pg/mL |
(solute-linked carrier famly 26 member A3)
oral food challenge (OFC):
References
- ↑ Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
- ↑ Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
- ↑ Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
- ↑ RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.
- ↑ Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
- ↑ Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
- ↑ BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.